Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway

Oncotarget

Volumn 7, Issue 43, 2016, Pages 70143-70151

  Mao, Hongwu ^a   Wang, Man ^a   Cao, Biyin ^a   Zhou, Haibin ^a   Zhang, Zubin ^a   Mao, Xinliang ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer; ISG15; NF B

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON STIMULATED GENE 15; PROTEIN MCL 1; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; CLIOQUINOL; ISG15 PROTEIN, HUMAN; MEFLOQUINE; PROTEINASE; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; USP18 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LENTIVIRINAE; LEUKEMIA; MYELOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; ANIMAL; BAGG ALBINO MOUSE; FEMALE; MOUSE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CLIOQUINOL; CYTOKINES; ENDOPEPTIDASES; FEMALE; HUMANS; MEFLOQUINE; MICE; MICE, INBRED BALB C; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

EID: 84994267546     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12160     Document Type: Article

References (21)

1. Zhang D, Zhang DE. Interferon-stimulated gene 15 and the protein ISGylation system. J Interferon Cytokine Res. 2011; 31:119-30. doi: 10.1089/jir.2010.0110.
2. Li C, Wang J, Zhang H, Zhu M, Chen F, Hu Y, Liu H, Zhu H. Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma. Oncotarget. 2014; 5:8429-41. doi: 10.18632/oncotarget.2316.
3. Sainz B Jr., Martin B, Tatari M, Heeschen C, Guerra S. ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells. Cancer Res. 2014; 74:7309-20. doi: 10.1158/0008-5472.CAN-14-1354.
4. Brown AR, Simmen RC, Raj VR, Van TT, MacLeod SL, Simmen FA. Kruppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling. Carcinogenesis. 2015; 36:946-55. doi: 10.1093/carcin/bgv104.
5. Chen RH, Du Y, Han P, Wang HB, Liang FY, Feng GK, Zhou AJ, Cai MY, Zhong Q, Zeng MS, Huang XM. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma. Oncotarget. 2016. doi: 10.18632/oncotarget.7626.
6. Wan XX, Chen HC, Khan MA, Xu AH, Yang FL, Zhang YY, Zhang DZ. ISG15 inhibits IFN-alpha-resistant liver cancer cell growth. Biomed Res Int. 2013; 2013:570909. doi: 10.1155/2013/570909.
7. Jeon YJ, Jo MG, Yoo HM, Hong SH, Park JM, Ka SH, Oh KH, Seol JH, Jung YK, Chung CH. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. J Clin Invest. 2012; 122:2622-36. doi: 10.1172/JCI61762.
8. Burks J, Reed RE, Desai SD. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective. Oncotarget. 2015; 6:7221-31. doi: 10.18632/oncotarget.3372.
9. Mao X, Li X, Sprangers R, Wang X, Venugopal A, Wood T, Zhang Y, Kuntz DA, Coe E, Trudel S, Rose D, Batey RA, Kay LE, et al. Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma. Leukemia. 2009; 23:585-90. doi: 10.1038/leu.2008.232.
10. Sukhai MA, Prabha S, Hurren R, Rutledge AC, Lee AY, Sriskanthadevan S, Sun H, Wang X, Skrtic M, Seneviratne A, Cusimano M, Jhas B, Gronda M, et al. Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors. J Clin Invest. 2013; 123:315-28. doi: 10.1172/JCI64180.
11. Liu M, Hummer BT, Li X, Hassel BA. Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon. J Interferon Cytokine Res. 2004; 24:647-54. doi: 10.1089/jir.2004.24.647.
12. Guo Y, Dolinko AV, Chinyengetere F, Stanton B, Bomberger JM, Demidenko E, Zhou DC, Gallagher R, Ma T, Galimberti F, Liu X, Sekula D, Freemantle S, et al. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARalpha and inhibits the growth of acute promyelocytic leukemia. Cancer Res. 2010; 70:9875-85. doi: 10.1158/0008-5472.CAN-10-1100.
13. Zhang Z, Mao H, Du X, Zhu J, Xu Y, Wang S, Xu X, Ji P, Yu Y, Cao B, Han K, Hou T, Xu Z, et al. A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway. Oncotarget. 2016 doi: 10.18632/oncotarget.6974.
14. Hadjivasiliou A. ISG15 implicated in cytoskeleton disruption and promotion of breast cancer. Expert Rev Proteomics. 2012; 9:7.
15. Burks J, Reed RE, Desai SD. ISGylation governs the oncogenic function of Ki-Ras in breast cancer. Oncogene. 2014; 33:794-803. doi: 10.1038/onc.2012.633.
16. Huang YF, Wee S, Gunaratne J, Lane DP, Bulavin DV. Isg15 controls p53 stability and functions. Cell Cycle. 2014; 13:2200-10. doi: 10.4161/cc.29209.
17. Minakawa M, Sone T, Takeuchi T, Yokosawa H. Regulation of the nuclear factor (NF)-kappaB pathway by ISGylation. Biol Pharm Bull. 2008; 31:2223-7.
18. Ling C, Chen G, Chen G, Zhang Z, Cao B, Han K, Yin J, Chu A, Zhao Y, Mao X. A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo. Int J Cancer. 2012; 131:2411-9. doi: 10.1002/ijc.27504.
19. Sharmeen S, Skrtic M, Sukhai MA, Hurren R, Gronda M, Wang X, Fonseca SB, Sun H, Wood TE, Ward R, Minden MD, Batey RA, Datti A, et al. The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood. 2010; 116:3593-603. doi: 10.1182/blood-2010-01-262675.
20. Xu X, Han K, Tang X, Zeng Y, Lin X, Zhao Y, Zhang Z, Cao B, Wu D, Mao X. The ring finger protein RNF6 induces leukemia cell proliferation as a direct target of pre-B-cell leukemia homeobox 1. J Biol Chem. 2016. doi: 10.1074/jbc. M115.701979.
21. Zhang Z, Tong J, Tang X, Juan J, Cao B, Hurren R, Chen G, Taylor P, Xu X, Shi CX, Du J, Hou J, Wang G, et al. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice. Blood. 2016; 127:1676-86. doi: 10.1182/blood-2015-07-658203.